2Garay G,Dupont J,Dragosky M, et al, Combination salvage chemotherapy with MIZE (ifosfamide and etoposide) for relapsing or refractory lymphoma[J].Lymphoma,1997,26:595. 被引量：1
3Plantier Colcher,Dupriez B,Simon M, et al.The VIMB-AraC regimen followed by antologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin′s lymphoma.A prospective study of 71 consecutive cases[J].Leukemia,1999,13:282. 被引量：1
4Amadori S,Pieardi A,Fazi P,et al.A phase study of VP-16,intermediate dose Ara-C and carboplatine(VAC) in aduanced acute myelogenoous lenkeuisa and blastic chrouic myelogenous lenkeuia[J].Leukeuia,1996,10:766. 被引量：1
5Spadea A,Petti M C,Fazi P,et al.Mitoxantrone,etoposide and intermediate doseAra-C(MEC):an effective regimen for poor risk acute myeloid leukemia[J].Leukemia,1993,7:549. 被引量：1
6Link H. Mitoxantrone,eytosin arabinsoide and VP16 in 36 patients with relapsed and refractory acute myeloid leukemia[J]. Haematol Blood Transfusion,1990,33:332. 被引量：1
